Video Archives

High-Risk/BCG Naïve: Treatment of Choice

Michael A. O’Donnell, MD, discusses BCG’s role as the standard treatment for non-muscle invasive bladder cancer (NMIBC).

Posted by Ariana L. Smith, MD | Apr 2025

Ariana L. Smith, MD, highlights the achievements of the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium.

Posted by Yair Lotan, MD | Apr 2025

Yair Lotan, MD, discusses urinary biomarkers and highlights their evolving role in bladder cancer detection and surveillance.

William O. Brant, MD, FACS, FECSM, explores surgical approaches for Peyronie’s disease, focusing on penile curvature correction.

Posted by Alberto Vargas, MD | Apr 2025

Alberto Vargas, MD, examines the integration of AI into prostate MRI, focusing on its current state, challenges, and future implications.